Market Movers Today: Tetraphase Pharmaceuticals Inc (TTPH), Twilio Inc (TWLO), Genesco Inc. (GCO), Nektar Therapeutics (NKTR), and More

Page 2 of 2

Motus GI Holdings Inc. (NASDAQ:MOTS) (MarketWatch)
Shares of medical device company Motus GI Holdings MOTS, -6.60% fell about 8% in their trading debut Wednesday, after the company priced its initial public offering at the low end of its $5 to $7 range. The Israeli company sold 3.5 million shares to raise $18.5 million. The company was originally planning to offer 4.3 million shares but reduced the size of the deal ahead of pricing. Few companies have braved the IPO market this week, given the recent volatility and a traditional seasonal lull as financials are updated.

DBV Technologies SA – ADR (NASDAQ:DBVT) (Benzinga)
DBV Technologies SA – ADR shares jumped 25.2 percent to $26.11 after the company disclosed that the U.S. FDA has agreed that the available efficacy and safety data for Viaskin Peanut supports the submission of a BLA for the treatment of peanut allergy in children four to 11 years of age.

Chipotle Mexican Grill, Inc. (NYSE:CMG) (The Motley Fool)
What happened: Shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) were heating up today after the addled burrito chain named a new CEO, tapping Brian Niccol, the CEO of Yum! Brands’ (NYSE:YUM) Taco Bell, to lead its turnaround. Investors overwhelmingly approved of the decision, sending the stock up 15% as of 11:43 a.m. EST.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) (Benzinga)
Galmed Pharmaceuticals Ltd shares tumbled 51.7 percent to $4.57 after the company disclosed that its top line data from the ARRIVE study did not meet its primary endpoint. Maxim Group downgraded Galmed Pharmaceuticals from Buy to Hold.

Home Depot Inc (NYSE:HD) (CNBC)
Home Depot shares have been on shaky ground this month, falling 9 percent. But, one technically minded trader says its foundation is still solid.”If we see another downdraft in the broad market that takes it down to the 200-day moving average, that could be a real good entry point to either add to old positions or add new positions,” Matt Maley, equity strategist at Miller Tabak, told CNBC’s “Trading Nation” on Tuesday. Home Depot’s 200-day moving average is $166.78, or 8 percent lower than its current price.






Page 2 of 2